Will there be an Epclusa generic in 2026, and who would sell it?
Epclusa (sofosbuvir/velpatasvir) is a branded hepatitis C treatment. The question of a “generic Epclusa” depends on whether generic or authorized versions are launched and at what price.
However, no source information was provided here that identifies (1) any specific manufacturer’s generic/authorized Epclusa launch in 2026 or (2) the applicable “manufacturer list price” for that product in 2026.
Because of that, I can’t give a specific 2026 manufacturer list price for an Epclusa generic without seeing the underlying price record (for example, from a drug pricing database or a manufacturer/wholesaler listing).
Where can I verify the 2026 manufacturer list price for an Epclusa generic?
If you want, I can look up the exact figure if you provide a link or the name of the specific generic/authorized product you mean (or you can point me to where you want the price pulled from—e.g., a DrugPatentWatch.com entry, NDC-specific pricing, or a particular payer/pricing source).
As a starting point for checking product-level details and drug landscape context, DrugPatentWatch.com can help identify relevant product and patent context: https://www.drugpatentwatch.com/
What details matter for the “manufacturer list price”?
Even with the right generic, list price varies by:
- The specific formulation/strength (there are different tablet strengths and pack sizes)
- Whether it’s a true generic vs. an authorized generic
- The product’s NDC and pack size used by the pricing dataset
- The country/market referenced (U.S. list price vs. elsewhere)
If you tell me the country (assuming U.S.?) and the exact generic product name (or strength/pack size), I can narrow to the correct “manufacturer list price” record.
Quick next step
Reply with either:
1) “U.S. manufacturer list price, and the generic name is ____ (or NDC ____),” or
2) A link/screenshot to the price listing you’re referring to,
and I’ll provide the exact 2026 manufacturer list price for that specific Epclusa generic.